Dr. Paul J. Hesketh MD
Hematologist-Oncologist | Hematology & Oncology
Lahey Clinic 41 Mall Rd. Burlington MA, 01805About
Dr. Paul Hesketh is a hematologist oncologist practicing in Burlington, MA. Dr. Hesketh specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Univ Of Ct Sch Of Med- Farmington Ct 1978
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.
- Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice.
- Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis.
- Antiemetics for cancer chemotherapy-induced nausea and vomiting. A review of agents in development.
- Paclitaxel and concurrent radiation for gastric cancer.
- Comparative review of 5-HT3 receptor antagonists in the treatment of acute
- Antiemetic efficacy of single-dose oral granisetron (1 mg vs 2 mg) with moderately emetogenic chemotherapy.
- Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: a meta-analysis of randomized evidence.
- Potential role of the NK1 receptor antagonists in chemotherapy-induced nausea and vomiting.
- An ultrathin platinum film sensor to measure biomolecular binding.
- Prospective evaluation of antiemetic outcome following high-dose chemotherapy with hematopoietic stem cell support.
- Comparative trials of ondansetron versus metoclopramide in the prevention of acute cisplatin-induced emesis.
- The delayed-emesis syndrome from cisplatin: phase III evaluation of ondansetron versus placebo.
- Uncommon hematologic malignancies. Case 2. Calcification in untreated primary mediastinal large B-cell lymphoma with sclerosis.
- Adrenal hemorrhage secondary to metastasis from lung cancer.
Clinical Trials
- Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer
- Maintenance Chemotherapy With or Without Stereotactic Body Radiation Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
- Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
- Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
- Collaborative Advanced Stage Tissue Lung Cancer (CASTLE) Network
- Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
- Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)
- Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
- Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Dr. Paul J. Hesketh MD's Practice location
Burlington, MA 01805Get Direction
Dr. Paul J. Hesketh MD's reviews
Write ReviewPatient Experience with Dr. Hesketh
Recommended Articles
- Mr. T's Lessons on Life and Lymphoma
There are several things that Mr. T is known for, including his career as a WWF wrestler and his role as B.A. Baracus in the hit series ‘The A-Team’. To this day, he continues to remain a fun and stylish icon of the 80s. Nevertheless, Mr. T is not only known for his appearances on television,...
- The Lymphoma Research Foundation Announces Partnership with the Annals of Lymphoma
The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization for lymphoma research, and they just announced their partnership with the Annals of Lymphoma (AOL). This was all revealed in September during Blood Cancer Awareness Month. LRF is devoted to exclusively funding...
- 'Robocop' Stem Cells Developed to Fight Cancer
Cancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...
- What Are Lymphocytes?
A lymphocyte is a type of white blood cell (WBC) that has a significant function in the body's immune system. Lymphocytes function by properly responding to infectious microorganisms and other foreign invaders in the body. Lymphocytes can work alone, but some of them are also capable of...
- Treatments for Multiple Myeloma
The cancer care crew discusses what treatment will suit you after multiple myeloma has been diagnosed and staged. The following are treatments used in multiple myeloma:...
- Roles of the National Coalition for Cancer Survivorship
The National Coalition for Cancer Survivorship (NCCS) is a nonprofit, cancer advocacy organization that is located just outside of Washington D.C. To date, it is the oldest survivor-led cancer advocacy organization in the United States.The NCCS represents millions of Americans who share a common...
Nearby Providers
- Dr. Zheng Zhou M.D., PH.D.41 MALL RD BURLINGTON MA 01805
- Dr. Douglas Tisdale M.D.41 MALL RD LAHEY HOSPITAL AND MEDICAL CENTER BURLINGTON MA 01805
- Mr. Jacob Magee Sands MD41 BURLINGTON MALL RD. BURLINGTON MA 01805
- Dr. Hande Hayirlioglu Tuncer MD41 Mall Rd Burlington MA 01805
- Dr. Furha Cossor MD41 Mall Rd Burlington MA 01805
- Dr. Francis Nugent M.D.41 Mall Rd Burlington MA 01805